AAAAAA

   
Results: 1-9 |
Results: 9
BIOLOGICAL MATRIX-DEPENDENT PHARMACOKINETIC AND PHARMACODYNAMIC PARAMETERS OF A NOVEL PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR ANTAGONIST, XU063, IN BEAGLE DOGS/
Authors: KAPIL RP EMM TA MOUSA SA PADOVANI PK QUON CY LAM GN
Citation: Rp. Kapil et al., BIOLOGICAL MATRIX-DEPENDENT PHARMACOKINETIC AND PHARMACODYNAMIC PARAMETERS OF A NOVEL PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR ANTAGONIST, XU063, IN BEAGLE DOGS/, Thrombosis research, 86(3), 1997, pp. 221-232
ORAL ANTIPLATELET EFFECTS OF DMP-754 IN DOGS AND NONHUMAN-PRIMATES
Authors: RACANELLI AL KAPIL RP MOUSA SA REILLY TM THOOLEN MJ
Citation: Al. Racanelli et al., ORAL ANTIPLATELET EFFECTS OF DMP-754 IN DOGS AND NONHUMAN-PRIMATES, Circulation, 94(8), 1996, pp. 565-565
ORAL ANTIPLATELET, ANTITHROMBOTIC EFFICACY OF DMP-728, A NOVEL PLATELET GPIIB IIIA ANTAGONIST/
Authors: MOUSA SA DEGRADO WF MU DX KAPIL RP LUCCHESI BR REILLY TM
Citation: Sa. Mousa et al., ORAL ANTIPLATELET, ANTITHROMBOTIC EFFICACY OF DMP-728, A NOVEL PLATELET GPIIB IIIA ANTAGONIST/, Circulation, 93(3), 1996, pp. 537-543
DETERMINATION OF A NOVEL COGNITIVE ENHANCER, X9121, AND ITS MONO N-OXIDE METABOLITE, XG696, IN DOG PLASMA BY REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ULTRAVIOLET DETECTION
Authors: KAPIL RP LEE W PADOVANI PK WONG NY HOLM KA LAM GN
Citation: Rp. Kapil et al., DETERMINATION OF A NOVEL COGNITIVE ENHANCER, X9121, AND ITS MONO N-OXIDE METABOLITE, XG696, IN DOG PLASMA BY REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ULTRAVIOLET DETECTION, Journal of chromatography B. Biomedical applications, 665(1), 1995, pp. 226-231
DOSE-DEPENDENT AND SPECIES-DEPENDENT PHARMACOKINETICS OF A NOVEL SIGMA-RECEPTOR ANTAGONIST, DUP-734
Authors: KAPIL RP LAM GN
Citation: Rp. Kapil et Gn. Lam, DOSE-DEPENDENT AND SPECIES-DEPENDENT PHARMACOKINETICS OF A NOVEL SIGMA-RECEPTOR ANTAGONIST, DUP-734, Research communications in molecular pathology and pharmacology, 88(1), 1995, pp. 3-20
PHARMACOKINETICS AND PRESYSTEMIC HEPATIC FIRST-PASS ELIMINATION OF A NOVEL SIGMA-RECEPTOR ANTAGONIST, DUP-734, IN THE RAT
Authors: KAPIL RP LAM GN
Citation: Rp. Kapil et Gn. Lam, PHARMACOKINETICS AND PRESYSTEMIC HEPATIC FIRST-PASS ELIMINATION OF A NOVEL SIGMA-RECEPTOR ANTAGONIST, DUP-734, IN THE RAT, Drug metabolism and disposition, 23(5), 1995, pp. 603-606
DETERMINATION OF DMP-728, A IIB IIIA RECEPTOR ANTAGONIST, IN RAT AND DOG PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUOROMETRICDETECTION/
Authors: WU ST STAMPFLI HF BANKS CM EMM TA KAPIL RP PADOVANI PK LEE WM HUANG SM
Citation: St. Wu et al., DETERMINATION OF DMP-728, A IIB IIIA RECEPTOR ANTAGONIST, IN RAT AND DOG PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUOROMETRICDETECTION/, Journal of chromatography B. Biomedical applications, 657(1), 1994, pp. 254-260
DETERMINATION OF A NOVEL SIGMA-RECEPTOR ANTAGONIST, DUP-734, IN RAT PLASMA BY REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ULTRAVIOLET DETECTION
Authors: KAPIL RP LEE W WONG NY SAXTON PL LAM GN
Citation: Rp. Kapil et al., DETERMINATION OF A NOVEL SIGMA-RECEPTOR ANTAGONIST, DUP-734, IN RAT PLASMA BY REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ULTRAVIOLET DETECTION, Journal of chromatography B. Biomedical applications, 653(2), 1994, pp. 221-226
ANTIPLATELET AND ANTITHROMBOTIC EFFICACY OF DMP-728, A NOVEL PLATELETGPIIB IIIA RECEPTOR ANTAGONIST/
Authors: MOUSA SA BOZARTH JM FORSYTHE MS JACKSON SM LEAMY A DIEMER MM KAPIL RP KNABB RM MAYO MC PIERCE SK DEGRADO WF THOOLEN MJ REILLY TM
Citation: Sa. Mousa et al., ANTIPLATELET AND ANTITHROMBOTIC EFFICACY OF DMP-728, A NOVEL PLATELETGPIIB IIIA RECEPTOR ANTAGONIST/, Circulation, 89(1), 1994, pp. 3-12
Risultati: 1-9 |